UV Germi SA (EPA:ALUVI)
UV Germi Statistics
Total Valuation
UV Germi has a market cap or net worth of EUR 8.11 million. The enterprise value is 3.44 million.
Market Cap | 8.11M |
Enterprise Value | 3.44M |
Important Dates
The next estimated earnings date is Wednesday, July 30, 2025.
Earnings Date | Jul 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
UV Germi has 3.18 million shares outstanding.
Current Share Class | 3.18M |
Shares Outstanding | 3.18M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 2.96% |
Float | 1.02M |
Valuation Ratios
The trailing PE ratio is 11.42.
PE Ratio | 11.42 |
Forward PE | n/a |
PS Ratio | 0.91 |
PB Ratio | 0.82 |
P/TBV Ratio | 0.89 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 4.85 |
EV / Sales | 0.39 |
EV / EBITDA | 4.01 |
EV / EBIT | 6.87 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.03, with a Debt / Equity ratio of 0.01.
Current Ratio | 8.03 |
Quick Ratio | 5.67 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.11 |
Debt / FCF | n/a |
Interest Coverage | 410.37 |
Financial Efficiency
Return on equity (ROE) is 7.48% and return on invested capital (ROIC) is 3.26%.
Return on Equity (ROE) | 7.48% |
Return on Assets (ROA) | 2.92% |
Return on Invested Capital (ROIC) | 3.26% |
Return on Capital Employed (ROCE) | 5.06% |
Revenue Per Employee | 201,709 |
Profits Per Employee | 16,135 |
Employee Count | 44 |
Asset Turnover | 0.83 |
Inventory Turnover | 1.72 |
Taxes
Income Tax | -138,122 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.97% in the last 52 weeks. The beta is -0.14, so UV Germi's price volatility has been lower than the market average.
Beta (5Y) | -0.14 |
52-Week Price Change | -12.97% |
50-Day Moving Average | 2.42 |
200-Day Moving Average | 2.63 |
Relative Strength Index (RSI) | 58.21 |
Average Volume (20 Days) | 3,467 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, UV Germi had revenue of EUR 8.88 million and earned 709,927 in profits. Earnings per share was 0.22.
Revenue | 8.88M |
Gross Profit | 4.01M |
Operating Income | 501,474 |
Pretax Income | 571,805 |
Net Income | 709,927 |
EBITDA | 857,977 |
EBIT | 501,474 |
Earnings Per Share (EPS) | 0.22 |
Balance Sheet
The company has 4.76 million in cash and 91,992 in debt, giving a net cash position of 4.67 million or 1.47 per share.
Cash & Cash Equivalents | 4.76M |
Total Debt | 91,992 |
Net Cash | 4.67M |
Net Cash Per Share | 1.47 |
Equity (Book Value) | 9.88M |
Book Value Per Share | 3.11 |
Working Capital | 8.05M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 45.21%, with operating and profit margins of 5.65% and 8.00%.
Gross Margin | 45.21% |
Operating Margin | 5.65% |
Pretax Margin | 6.44% |
Profit Margin | 8.00% |
EBITDA Margin | 9.67% |
EBIT Margin | 5.65% |
FCF Margin | n/a |
Dividends & Yields
UV Germi does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 8.75% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
UV Germi has an Altman Z-Score of 7.09 and a Piotroski F-Score of 6.
Altman Z-Score | 7.09 |
Piotroski F-Score | 6 |